首页> 外文期刊>BMC Nephrology >Predicting the outcome of chronic kidney disease by the estimated nephron number: The rationale and design of PRONEP, a prospective, multicenter, observational cohort study
【24h】

Predicting the outcome of chronic kidney disease by the estimated nephron number: The rationale and design of PRONEP, a prospective, multicenter, observational cohort study

机译:通过估计的肾单位数预测慢性肾脏疾病的结果:PRONEP的原理和设计,一项前瞻性,多中心,观察性队列研究

获取原文
           

摘要

Background The nephron number is thought to be associated with the outcome of chronic kidney disease (CKD). If the nephron number can be estimated in the clinical setting, it could become a strong tool to predict renal outcome. This study was designed to estimate the nephron number in CKD patients and to establish a method to predict the outcome by using the estimated nephron number. Methods/Design The hypothesis of this study is that the estimated nephron number can predict the outcome of a CKD patient. This will be a multicenter, prospective (minimum 3 and maximum 5 years follow-up) study. The subjects will comprise CKD patients aged over 14 years who have undergone a kidney biopsy. From January 2011 to March 2013, we will recruit 600 CKD patients from 10 hospitals belonging to the National Hospital Organization of Japan. The primary parameter for assessment is the composite of total mortality, renal death, cerebro-cardiovascular events, and a 50% reduction in the eGFR. The secondary parameter is the rate of eGFR decline per year. The nephron number will be estimated by the glomerular density in biopsy specimens and the renal cortex volume. This study includes one sub-cohort study to establish the equation to calculate the renal cortex volume. Enrollment will be performed at the time of the kidney biopsy, and the data will consist of a medical interview, ultrasound for measurement of the kidney size, blood or urine test, and the pathological findings of the kidney biopsy. Patients will continue to have medical consultations and receive examinations and/or treatment as usual. The data from the patients will be collected once a year after the kidney biopsy until March 2016. All data using this study are easily obtained in routine clinical practice. Discussion This study includes the first trials to estimate the renal cortex volume and nephron number in the general clinical setting. Furthermore, this is the first prospective study to examine whether the nephron number predicts the outcome of CKD patients. The results from this study should provide powerful new tools for nephrologists in routine clinical practice. Trial registration UMIN-Clinical Trial Registration, UMIN000004784.
机译:背景肾单位数目被认为与慢性肾脏疾病(CKD)的结局有关。如果可以在临床环境中估计肾单位数目,则它可能成为预测肾脏预后的有力工具。这项研究旨在评估CKD患者的肾单位数目,并建立一种使用估计的肾单位数目预测结局的方法。方法/设计这项研究的假设是,估计的肾单位数可以预测CKD患者的预后。这将是一项多中心,前瞻性研究(至少3年,最长5年随访)。受试者将包括接受肾脏活检的14岁以上的CKD患者。从2011年1月到2013年3月,我们将从日本国家医院组织的10家医院招募600名CKD患者。评估的主要参数是总死亡率,肾死亡,脑心血管事件和eGFR降低50%的综合值。次要参数是每年eGFR下降的速度。肾单位数将由活检标本中的肾小球密度和肾皮质体积来估计。这项研究包括一项子队列研究,以建立计算肾皮质体积的方程式。登记将在进行肾脏活检时进行,数据将包括医学访谈,用于测量肾脏大小的超声检查,血液或尿液检查以及肾脏活检的病理结果。患者将继续像往常一样接受医疗咨询并接受检查和/或治疗。每年从肾脏活检到2016年3月,将收集患者的数据。使用本研究的所有数据均可在常规临床实践中轻松获得。讨论该研究包括首次评估总体临床环境中肾皮质体积和肾单位数目的试验。此外,这是第一项前瞻性研究,旨在检查肾单位数目是否可预测CKD患者的预后。这项研究的结果应为肾脏病医生的常规临床实践提供强大的新工具。试用注册UMIN-临床试用注册,UMIN000004784。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号